PRDM9 and cancer: A recent study showed that knock down of histone methyltransferase SET8, a target gene of miR-502, led to the inhibition of cell proliferation, colony formation, cellular migration, and invasion in RCC cells, implying the anti-cancer activity of miR-502 (44).